JustinMoyersMD

PubMed

• 13 citations
  Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Rev...
  Eric Lau, Justin T. Moyers, Billy C Wang, Il Seok Daniel Jeong, Joanne Lee
  Cancers. 2021-02-21
• 129 citations
  Development of immunotherapy combination strategies in cancer
  Timothy A. Yap, Eileen Parkes, Weiyi Peng, Justin T. Moyers, Michael A. Curran
  Cancer Discovery. 2021-04-02
• 25 citations
  Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine.
  Niamh Coleman, Justin T. Moyers, Alice Harbery, Igor Vivanco, Timothy A. Yap
  Pharmacogenomics and Personalized Medicine. 2021-01-01

Abstracts/Posters

• Assessment of investigational new drugs (INDs) approved in USA and Europe after early phase trials using the ESMO-magnitude of clinical benefit scale (ESMO-MCBS)
  J.T. Moyers, D.J. Benjamin, D. Brazel, P. Kumar, V. Subbiah, European Society of Medical Oncology Congress 2022, Paris, France, 9/10/2022
• Precision oncology and tumor mutational burden (TMB) in Merkel cell carcinoma (MCC): An analysis of the AACR Project Genie real-world database
  J.T. Moyers, D. Brazel, P. Kumar, European Society of Medical Oncology Congress 2022, Paris, France, 9/10/2022
• Immunotherapy in metastatic melanoma: A sociodemographic analysis of the National Cancer Database.
  Amie Patel, Justin Moyers, Gayathri Nagaraj, American Society of Clinical Oncology- Society of Immunotherapy in Cancer, Orlando, Florida, 2/4/2020
• Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Trials
  JT Moyers, J Rosczik, RC Pestana, V Subbiah, Connective Tissue Oncology Society, Virtual, 11/13/2021
• Adherence to the Food and Drug Administration (FDA) guidance for the co-development of two or more investigational new drugs in phase 1/2 cancer trials
  J.T. Moyers, D. Nguyen, D.S. Hong, E.E. Ileana Dumbrava, S. Fu, D. Karp, A. Naing, S. Pant, F. Janku, S.A. Piha-Paul, J. Rodon, V. Subbiah, A.M. Tsimberidou, F. Meric-..., European Society of Medical Oncology, Paris, France, 9/18/2021
• Treatment patterns and outcomes by age in metastatic melanoma: A study of the National Cancer Database
  Justin Moyers, Esther G Chong, Gayathri Nagaraj, 2020 ASCO Virtual Conference, 5/2020
• Treatment outcomes in melanoma with brain metastases in the era of immunotherapy: An analysis of the National Cancer Database
  Justin Moyers, Esther G Chong, Daniel Sufficool, Gayathri Nagaraj, ASCO 2020 Virtual Conference, 5/2020
• Single-Center Analysis of Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Hematologic Malignancies: Effects of Age and Eosinophilia
  Moyers, J; Desai, D; Mitchell, J; Ahn, J; Hardin, S; Thinn, M, Society of Immunotherapy of Cancer, National Harbor, Maryland, 11/8/2019
• Single-center analysis of post-transplant lymphoproliferative disorder (PTLD) outcomes with Epstein Barr virus (EBV) assessments.
  Justin Moyers, Lawrence Liu, Matthew Kim, Huan Mo, Muhammad Omair Kamal, Rafael Villacana, Chien-Shing Chen, Huynh Le Cao, ASCO 2019, 6/1/2019
• "Primary Pulmonary Non-Hodgkin's Lymphoma: Expanding the GroundGlass Opacification Differential
  Moyers, Justin; Sasich, Randy, American Thoracic Society, Washington D.C., 5/23/2017
• Don't Stop the Bleeding: An Atypical case of HUS
  Moyers, Justin, Oregon Chapter of American College of Physicians, Salem, Oregon, 11/10/2016
• Join now to see all